Publications by authors named "Ingo Wolf"

Claim this Profile
T
The critical role of emotional communication for motivated reasoning.
Ingo Wolf, Tobias Schröder

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visions for our future regional electricity system: Citizen preferences in four EU countries.
Franziska Mey, Johan Lilliestam, Ingo Wolf, Tim Tröndle

iScience· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminative Long-Distance Transport of Selenate and Selenite Triggers Glutathione Oxidation in Specific Subcellular Compartments of Root and Shoot Cells in .
Muhammad Sayyar Khan, Anna Soyk, Ingo Wolf, Miriam Peter, Andreas J Meyer

Front Plant Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociotopy in the temporoparietal cortex: common versus distinct processes.
Markus Bahnemann, Isabel Dziobek, Kristin Prehn, Ingo Wolf, Hauke R Heekeren

Soc Cogn Affect Neurosci· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural correlates of social cognition in naturalistic settings: a model-free analysis approach.
Ingo Wolf, Isabel Dziobek, Hauke R Heekeren

Neuroimage· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.
Michael J Willhauck, Bibi-Rana Sharif Samani, Ingo Wolf, Reingard Senekowitsch-Schmidtke, Hans-Jürgen Stark, Wolfram H Knapp

Eur J Nucl Med Mol Imaging· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression.
Michael J Willhauck, Bibi-Rana Sharif Samani, Franz-Josef Gildehaus, Ingo Wolf, Reingard Senekowitsch-Schmidtke

J Clin Endocrinol Metab· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(111)In]DOTATOC as a dosimetric substitute for kidney dosimetry during [(90)Y]DOTATOC therapy: results and evaluation of a combined gamma camera/probe approach.
Alexander Stahl, Sylvia Schachoff, Ambros Beer, Anna Winter, Hans Jürgen Wester, Ingo Wolf

Eur J Nucl Med Mol Imaging· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression.
Ambros J Beer, Roland Haubner, Ingo Wolf, Michael Goebel, Stephan Luderschmidt, Wolfgang A Weber

J Nucl Med· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.
Günther Meisetschläger, Thorsten Poethko, Alexander Stahl, Ingo Wolf, Klemens Scheidhauer

J Nucl Med· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide.
Alexander Stahl, Günther Meisetschläger, Margret Schottelius, Kjerstin Bruus-Jensen, Ingo Wolf

Eur J Nucl Med Mol Imaging· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of individual S-values for 131I using segmented CT data and the EGS4 Monte Carlo code.
Ingo Wolf, Maria Zankl, Klemens Scheidhauer, Eugenia Vabuliene, Dieter Regulla

Cancer Biother Radiopharm· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and kinetics of (131)I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma.
Klemens Scheidhauer, Ingo Wolf, Hans-Joachim Baumgartl, Christoph Von Schilling, Burkhard Schmidt

Eur J Nucl Med Mol Imaging· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics.
Hans-Jürgen Wester, Margret Schottelius, Klemens Scheidhauer, Jean-Claude Reubi, Ingo Wolf

Eur J Nucl Med Mol Imaging· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis